The effects of ruthenium red (RR) on transmitter release and pre-synap
tic currents were studied in the mouse neuromuscular junction. The act
ion of RR (10 mu M) was shown not only in the complete suppression of
nerve-evoked muscle contractions associated with the-depression of end
plate potential amplitudes but also in the partial inhibition of the a
mplitude of miniature-endplate potentials. However, the other rutheniu
m compounds, ruthenium chloride and tris (2,2-bipyridyl) ruthenium chl
oride did not significantly affect the neuromuscular transmission. In
pre-synaptic waveform studies, the fast K+-current [IK(f)] as well as
the Ca2+-activated K+-current [IK(ca)] was significantly enhanced by 1
0 mu M RR. Furthermore, 10 mu M RR antagonized the action of beta-bung
arotoxin (a blocker of slow K+-channel [IK(s)] in enhancing pre-synapt
ic Ca2+ currents. In contrast, the typical Ca2+-channel blockers, omeg
a-agatoxin (0.5 mu M), Gd3+ (0.5 mM) and Cd2+ (0.3 mM) all suppressed
the IK(ca). Although RR (1-30 mu M) inhibited the Ca2+-currents of the
nerve terminals induced by the combined treatment with the K+-channel
blockers, 3,4-diaminopyridine plus tetraethylammonium chloride in a c
oncentration-dependent manner, it is considered that RR-enhanced K+ cu
rrents were responsible for, at least in part, the observed inhibition
of the Ca2+-current which led to the blockade of transmitter release.
Copyright (C) 1996 Elsevier Science Ltd